TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr |
What is the latest Total Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹43,614 Cr |
| Mar2025 | ₹14,396 Cr |
| Mar2024 | ₹14,505 Cr |
| Mar2023 | ₹14,468 Cr |
| Mar2022 | ₹12,606 Cr |
How is Total Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹43,614 Cr | 202.97 | |
| Mar2025 | ₹14,396 Cr | -0.76 | |
| Mar2024 | ₹14,505 Cr | 0.26 | |
| Mar2023 | ₹14,468 Cr | 14.77 | |
| Mar2022 | ₹12,606 Cr | - | |
Compare Total Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹190,848.6 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹105,357.0 Cr | -1% | 3.7% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.4% |
11% |
40.8% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses